edoxaban

Poland

Drugs containing this active substance

  • DELIANDA

    Delianda is used in adults to prevent blood clots in the brain and other blood vessels (in people with atrial fibrillation and additional risk factors), as well as to treat deep vein thrombosis in the lower limbs and pulmonary embolism, and to prevent their recurrence.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 15 mg

    ATC: B01AF03

    Manufacturer: Krka, d.d., Novo mesto

  • The medicine is used in adults to prevent blood clots in the brain (stroke) and other blood vessels (in atrial fibrillation with additional risk factors), as well as to treat deep vein thrombosis in the lower limbs and pulmonary embolism, and to prevent their recurrence.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 30 mg

    ATC: B01AF03

    Manufacturer: Krka, d.d., Novo mesto

  • The medicine is used in adults to prevent blood clots from forming in the brain and other blood vessels (in people with atrial fibrillation and additional risk factors), as well as to treat deep vein thrombosis in the lower limbs and pulmonary embolism, and to prevent their recurrence.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 60 mg

    ATC: B01AF03

    Manufacturer: Krka, d.d., Novo mesto

  • Edoflusio is used in adults to prevent blood clots in the brain (stroke) and in other blood vessels if heart rhythm disorders (atrial fibrillation) are present along with additional risk factors. It is also used to treat deep vein thrombosis in the legs and pulmonary embolism, as well as to prevent the recurrence of these clots.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 15 mg

    ATC: B01AF03

    Manufacturer: Lek Pharmaceuticals d.d.

  • This medicine is used in adults to prevent blood clots in the brain and other blood vessels (if atrial fibrillation and additional risk factors are present), as well as to treat blood clots in the veins of the legs and pulmonary vessels and to prevent them from occurring again.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 30 mg

    ATC: B01AF03

    Manufacturer: Lek Pharmaceuticals d.d.

  • This medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and in other blood vessels if atrial fibrillation and additional risk factors are present. It is also used to treat deep vein thrombosis in the legs and pulmonary embolism, and to prevent the recurrence of these clots.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 60 mg

    ATC: B01AF03

    Manufacturer: Lek Pharmaceuticals d.d.

  • This medicine is used in adults to prevent blood clots in the brain (stroke) and in other blood vessels if non-valvular atrial fibrillation and additional risk factors are present. It is also used to treat deep vein thrombosis in the lower limbs and pulmonary embolism, and to prevent the recurrence of these clots.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 15 mg

    ATC: B01AF03

    Manufacturer: Genericon Pharma Ges.m.b.H. PharOS Mt Ltd Pharos Pharmaceutical Oriented Services Ltd.

  • The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (in atrial fibrillation), as well as to treat deep vein thrombosis of the lower limbs and pulmonary embolism, and to prevent their recurrence.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 30 mg

    ATC: B01AF03

    Manufacturer: Genericon Pharma Ges.m.b.H. PharOS Mt Ltd Pharos Pharmaceutical Oriented Services Ltd.

  • The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (in atrial fibrillation with additional risk factors), as well as in the treatment of deep vein thrombosis in the lower limbs and pulmonary embolism, and to prevent their recurrence.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 60 mg

    ATC: B01AF03

    Manufacturer: Genericon Pharma Ges.m.b.H. PharOS Mt Ltd Pharos Pharmaceutical Oriented Services Ltd.

  • The medicine helps to prevent the formation of blood clots. It is used in adults to prevent strokes and blood clots in other blood vessels (in atrial fibrillation), as well as in the treatment and prevention of recurrence of deep vein thrombosis in the lower limbs and pulmonary embolism.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 15 mg

    ATC: B01AF03

    Manufacturer: Krka, d.d., Novo mesto

  • This medicine is used in adults to prevent blood clots from forming in the brain (stroke) and other blood vessels if heart rhythm disorders (atrial fibrillation) and additional risk factors are present. It is also used to treat deep vein thrombosis in the legs and pulmonary embolism, as well as to prevent the recurrence of these clots.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 30 mg

    ATC: B01AF03

    Manufacturer: Krka, d.d., Novo mesto

  • The medicine helps to prevent the formation of blood clots. It is used in adults to prevent strokes and blood clots in other blood vessels (if atrial fibrillation and additional risk factors are present), as well as in the treatment and prevention of recurrence of deep vein thrombosis and pulmonary embolism.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 60 mg

    ATC: B01AF03

    Manufacturer: Krka, d.d., Novo mesto

  • Exablok is used in adults to prevent the formation of blood clots in the brain and other blood vessels (in individuals with atrial fibrillation and additional risk factors), as well as to treat deep vein thrombosis and pulmonary embolism and to prevent their recurrence.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 15 mg

    ATC: B01AF03

    Manufacturer: Actavis Ltd., TEVA Pharmaceutical Works Ltd. (TEVA Pharmaceutical Works Private Limited Company), Teva Operations Poland Sp. z o.o.

  • The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (if atrial fibrillation and additional risk factors are present), as well as in the treatment and prevention of recurrence of thrombosis in the veins of the legs and in the pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 30 mg

    ATC: B01AF03

    Manufacturer: Actavis Ltd., TEVA Pharmaceutical Works Ltd. (TEVA Pharmaceutical Works Private Limited Company), Teva Operations Poland Sp. z o.o.

  • Exablok is used in adults to prevent the formation of blood clots in the brain and other blood vessels (in people with atrial fibrillation and additional risk factors), as well as to treat deep vein thrombosis and pulmonary embolism and to prevent their recurrence.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 60 mg

    ATC: B01AF03

    Manufacturer: Actavis Ltd., TEVA Pharmaceutical Works Ltd. (TEVA Pharmaceutical Works Private Limited Company), Teva Operations Poland Sp. z o.o.

  • Kymbek is used in adults to prevent blood clots in the brain (stroke) and other blood vessels in people with atrial fibrillation and additional risk factors. It is also used to treat deep vein thrombosis in the legs and pulmonary embolism, as well as to prevent the recurrence of these clots.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 15 mg

    ATC: B01AF03

    Manufacturer: PharOS MT Ltd. Pharos Pharmaceutical Oriented Services Ltd.

  • Kymbek is used in adults to prevent blood clots in the brain (stroke) and other blood vessels (if atrial fibrillation and additional risk factors are present) and to treat and prevent the recurrence of blood clots in the veins of the legs and pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 30 mg

    ATC: B01AF03

    Manufacturer: PharOS MT Ltd. Pharos Pharmaceutical Oriented Services Ltd.

  • Kymbek is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (in atrial fibrillation), as well as to treat deep vein thrombosis in the legs and pulmonary embolism, and to prevent their recurrence.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 60 mg

    ATC: B01AF03

    Manufacturer: PharOS MT Ltd. Pharos Pharmaceutical Oriented Services Ltd.

  • The medicine is used in adults to prevent the formation of blood clots in the brain and other blood vessels (in people with atrial fibrillation and additional risk factors), as well as to treat deep vein thrombosis in the legs and pulmonary embolism, and to prevent their recurrence.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 15 mg

    ATC: B01AF03

    Manufacturer: Labormed-Pharma S.A. Zentiva, k.s.

  • The medicine is used in adults to prevent the formation of blood clots in the brain and other blood vessels (in people with atrial fibrillation and additional risk factors), as well as to treat deep vein thrombosis and pulmonary embolism and to prevent their recurrence.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 30 mg

    ATC: B01AF03

    Manufacturer: Labormed-Pharma S.A. Zentiva, k.s.

  • The medicine is used in adults to prevent the formation of blood clots in the brain and other blood vessels (in people with atrial fibrillation and additional risk factors), as well as for the treatment and prevention of recurrence of deep vein thrombosis in the legs and pulmonary embolism.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 60 mg

    ATC: B01AF03

    Manufacturer: Labormed-Pharma S.A. Zentiva, k.s.